Presentation of Ten Abstracts Using Singulex's SMC(TM)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Presentation of Ten Abstracts Using Singulex's SMC(TM) Technology and Preview of Sgx Clarity(TM) System Are Featured at ESC Congress 2014

ALAMEDA, Calif., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer and leading provider of SMC™ technology for clinical diagnostics and scientific discovery, today announced the presentation of ten abstracts at the European Society of Cardiology's (ESC) annual conference, which highlight the clinical utility of single molecule counting technology in the detection and quantification of biomarkers for cardiac disease, its comorbidities, and its risk factors. The conference, held in Barcelona, Spain from August 30 th through September 3 rd , also featured the first European preview of the Sgx Clarity™ System, a fully-automated, SMC-powered in vitro diagnostics system targeted for launch to European hospitals and reference labs in 2016.

Three of the ten abstracts accepted by ESC Congress 2014 were selected for oral presentations:

Ultra-sensitive troponin I strongly predicts incident coronary heart disease in the general population independently of traditional risk factors. Results from the MONICA/KORA Augsburg Case-Cohort Study

Dr. Wolfgang Koenig, MD, PhD, Professor of Medicine/Cardiology at the Department of Internal Medicine II – Cardiology at the University of Ulm Medical School, Ulm, Germany, reported that even modestly increased cardiac Troponin I (cTnI) levels are strongly associated with incident coronary heart disease (CHD) independent of standard risk factors. Using Singulex's highly sensitive cTnI research-use-only immunoassay, the long-term, population-based, prospective study found that cTnI was detectable in almost every healthy middle-aged subject. Incident CHD subjects had a higher baseline cTnI level than subjects who did not develop CHD (geometric mean 2.56 vs. 1.49 ng/L, p<0.0001).

"Singulex's highly-sensitive cTnI assay has enabled us to predict the incidence of coronary heart disease in the general population," stated Dr. Koenig. "I believe we now have the ability to gain greater insight into the cardiovascular risk profile of individuals who have not already been diagnosed with the disease."

Incremental value of single resting ultrasensitive cardiac Troponin I measurement to rule-out myocardial ischemia

Dr. Yunus Tanglay, MD, Department of Cardiology, Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland, presented the results of a study that determined that cTnI levels complement non-invasive clinical assessments in patients with suspected coronary artery disease (CAD). cTnI levels were measured using Singulex's highly sensitive cTnI research-use-only immunoassay in 714 patients without known CAD before and after a bicycle exercise stress-test. Myocardial ischemia (MIS) was detected in 167 (23.4%) patients, and cTnI levels were significantly higher in patients with MIS (4.0 ng/L [95% CI 2.8-8.6] vs. 2.6 ng/L [95% CI 1.8-4.1], p<0.001). Diagnostic accuracy of CAD increased when both clinical judgment and cTnI levels were considered prior to a patient's stress test.

Plasma Kidney Injury Molecule (KIM-1) and Endothelin-1 (ET-1) are associated with worsening renal function in Heart Failure patients

Dr. Eitan Friedman, MD, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, stated that this study was the first to demonstrate that KIM-1 was not only quantifiable in plasma, but also serves as a biomarker for worsening renal function in heart failure (HF) patients. Elevation in urinary KIM-1 is a known indication of renal tubule epithelial damage, however, this study was the first to establish the biomarker's utility in plasma. ET-1, a low abundance, known plasma biomarker of endothelial function, was also found to be independently associated with worsening kidney function in HF patients. Renal dysfunction is a comorbidity of HF.

The following abstracts were presented in a poster presentation:

  • The clinical benefit of ultrasensitive cardiac Troponin I in the detection of exercise-induced myocardial ischemia
  • Novel dual-biomarker strategy and clinical judgment in the detection of exercise-induced myocardial ischemia
  • Subclinical inflammation quantified by Interleukin-6 for detection of exercise-induced myocardial ischemia
  • Cardiac Biomarkers pMMP-9, IL-6, and ET-1 are elevated in asymptomatic patients at risk of heart failure and associate with disease severity
  • Plasma Kidney Injury Molecule (KIM-1) and Endothelin-1 (ET-1) are associated with worsening renal function in Heart Failure patients
  • Glucagon like peptide-1 and blood pressure in young, healthy adults: a population-based study
  • Plasma glucagon-like-peptide 1 and body fat mass among young and healthy adults
  • Plasma endothelin-1 and risk of obstructive sleep apnea among young and healthy adults

Commenting on the significance of the abstract findings presented at the Congress, Guido Baechler, President and Chief Executive Officer of Singulex, stated, "Cardiovascular disease is the leading cause of death in the European Union, and thanks to our academic collaborators, we are even more confident that our SMC technology can offer a means to better detect, assess, and manage CVD patients, along- with associated comorbidities and risk factors. As these study findings indicate, with the launch of the SMC technology-based Sgx Clarity System in 2016, European physicians will have at their disposal a powerful diagnostic tool and unique portfolio of tests to drive evidence-based management of patients and improved outcomes."

About Singulex, Inc.

Singulex is the developer and leading provider of SMC™ technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultrasensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Singulex provides SMC technology to leading pharmaceutical R&D laboratories, clinical research organizations (CROs) and academic institutions around the world through its research-use-only Erenna® Immunoassay System. The Singulex Clinical Lab Testing Services consist of a CLIA-licensed and CAP-accredited laboratory that currently provides a comprehensive menu of advanced cardiovascular disease testing utilizing SMC technology. Singulex currently is developing the Sgx Clarity™ System, a fully-automated in vitro diagnostics system that will bring the benefits of its SMC technology to hospital and reference labs worldwide. For further information, please visit www.singulex.com .

Media: Mariesa Kemble +1 608.850.4745 Investors: Chris Kim Blueprint Life Science Group +1 415.375.3340 Ext. 101

Scroll down for more posts ▼

Top 10 Most Recent News Articles

XKIG Bolsters Northwest with Jensen's Acquisition

Updated Category News Views 13

Stepping Up the Game in the Pacific Northwest Well, here we see another classic example of a shrewd move in the infrastructure sector. XKIG, a name known to those who keep an eye on critical infrastructure services for utilities, has decided to widen its footprint with a strategic grab of Jensen's Tree Service, Inc. They’re setting up shop even deeper in the Pacific...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 152

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 77

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 160

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 92

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
NaLA Pushes for Stronger Lifeline Fraud Measures

Updated Category News Views 31

Here's the thing about the Lifeline program: it's meant to be a lifeline, not a loophole for the crafty and unscrupulous. The National Lifeline Association (NaLA) is slamming the table, demanding that the Senate Commerce Committee put some real muscle into preventing fraud. Why the Urgency on Lifeline Fraud? NaLA’s got its sights on a more robust defensive line against...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 42

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 52

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 104

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 22

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading

Top 5 Most Recently Viewed Articles

Ethan Allen Launches Stylish Design Center in Colorado Springs

Updated Category News Views 229

Introducing the New Ethan Allen Design Center Ethan Allen has proudly opened its latest Design Center in Colorado Springs, situated in the vibrant University Village Shopping Center. This newly constructed space features a beautiful gallery showroom, along with workspaces designed for collaboration between designers and clients. This new center is the fourth for Ethan...

Continue Reading
Understanding Ark Invest's Strategic Moves with AI Leaders

Updated Category News Views 349

Ark Invest's Bold Moves in the AI Sector Cathie Wood, the impactful leader of Ark Invest, continues to make headlines with her investment decisions. Recently, Ark made some noteworthy trades involving Baidu Inc. (NASDAQ: BIDU), Alibaba Group Holding Ltd. (NYSE: BABA), and Brera Holdings PLC (NASDAQ: BREA). These investments spotlight Ark's belief in companies championing...

Continue Reading
Broadcom's Future: Analyst Ratings Fuel Optimism for 2026

Updated Category News Views 287

Broadcom's Impressive Rally and Analysts' Confidence Recently, semiconductor giant Broadcom saw a remarkable rebound, achieving a staggering total return of 51%. This performance stands in sharp contrast to the previous year's underwhelming conclusion. Investors have taken a keen interest in the company, especially as it consistently outpaces the S&P 500’s return, which...

Continue Reading
Novavax's Earnings Preview: What Investors Should Expect

Updated Category News Views 160

Key Insights Before Novavax's Earnings Report Novavax (NASDAQ: NVAX) is set to announce its quarterly earnings soon, and anticipation is building among investors. This overview highlights essential factors for those interested in the upcoming earnings report. Expected Earnings Performance Analysts predict that Novavax will report an earnings per share (EPS) of...

Continue Reading
Bank7 Corp. Reports Impressive Q3 2024 Earnings Results

Updated Category News Views 130

Bank7 Corp. Achieves Record Earnings for Q3 2024 Bank7 Corp. (NASDAQ: BSVN), the parent company of Bank7, has announced outstanding financial results for the third quarter of 2024. In a recent statement, President and CEO Thomas L. Travis remarked, "We are pleased to announce another record quarter of net income and EPS. Our properly matched balance sheet, disciplined...

Continue Reading